ConductScience.org, home

Trial · NCT03673462

Results by group58

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Immediate Unsolicited Systemic Adverse Events (AEs)Group 1: MenACYW Conjugate Vaccine7Participants
Number of Participants With Immediate Unsolicited Systemic Adverse Events (AEs)Group 2: MENVEO®2Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccineMenACYW or MENVEO: Injection site Tenderness1501Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®MenACYW or MENVEO: Injection site Tenderness499Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccineMenACYW or MENVEO: Injection site Erythema826Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®MenACYW or MENVEO: Injection site Erythema257Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccineMenACYW or MENVEO: Injection site Swelling557Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®MenACYW or MENVEO: Injection site Swelling170Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccinePENTACEL: Injection site Tenderness1388Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®PENTACEL: Injection site Tenderness456Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccinePENTACEL: Injection site Erythema770Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®PENTACEL: Injection site Erythema255Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccinePENTACEL: Injection site Swelling562Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®PENTACEL: Injection site Swelling178Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccinePREVNAR 13: Injection site Tenderness1464Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®PREVNAR 13: Injection site Tenderness496Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccinePREVNAR 13: Injection site Erythema889Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®PREVNAR 13: Injection site Erythema298Participants
Number of Participants With Solicited Injection Site ReactionsGroup 1: MenACYW Conjugate VaccinePREVNAR 13: Injection site Swelling656Participants
Number of Participants With Solicited Injection Site ReactionsGroup 2: MENVEO®PREVNAR 13: Injection site Swelling206Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03673462/results